Outcomes of LAAO vs. DOACs in Obese Patients With Atrial Fibrillation a 5‐Year Propensity‐Matched Analysis
Pacing and Clinical Electrophysiology · 2026
DOI: 10.1111/pace.70089 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pacing and Clinical Electrophysiology, 2026. Verfasst von Mohamad Mdaihly und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Cleveland Clinic, Cardiac Electrophysiology and Pacing Section, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Obesity, Atrial Appendage, Anticoagulants. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Obese patients with atrial fibrillation (AF) are at an increased risk of thromboembolic and bleeding events. While direct oral anticoagulants (DOACs) are the standard therapy for stroke prevention in AF, their use is associated with a significant bleeding risk in this population. Comparative data of left appendage atrial occlusion (LAAO) vs. DOACs in this group are currently lacking.
Objective
To compare the 5‐year clinical outcomes of LAAO vs. DOACs in obese patients with AF.
Methods
Data were extracted from the TriNetX database, identifying obese patients with AF (BMI ≥40 kg/m 2 ). Two cohorts were defined: those undergoing LAAO ( n = 1571) and those treated with DOACs ( n = 103,047). Propensity score matching was conducted to adjust for demographics, comorbidities, and stroke/bleeding risk scores, resulting in matched cohorts of 1566 patients each. Outcomes assessed included ischemic stroke, non‐traumatic intracranial hemorrhage, major bleeding, MI, and all‐cause mortality. Kaplan–Meier survival curves and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated for group comparisons.
Results
At 5 years, stroke rates were similar between LAAO and DOAC groups (HR:1.00; 95% CI: 0.69–1.43; p = 0.984), as were major bleeding rates similar (HR:0.99; 95% CI: 0.71–1.42; p = 0.969). MI risk was comparable between the groups (HR:1.05; 95% CI: 0.66–1.36; p = 0.772). Importantly, LAAO was associated with lower all‐cause mortality (HR:0.64; 95% CI: 0.54–0.76; p < 0.001).
Conclusions
In obese patients with AF, LAAO offers a comparable stroke and bleeding protection to DOACs, while reducing all‐cause mortality over 5 years. These findings underscore the potential of LAAO as a long‐term strategy for stroke prevention in this high‐risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Cleveland Clinic, Cardiac Electrophysiology and Pacing Section, Cleveland, Ohio, USA.
ORCID-Profile: Mohamad Mdaihly, Joe Demian, Adele Watfa
Zitieren
APA
Mdaihly, M., Motairek, I., Younis, A., Tabaja, C., Demian, J., Watfa, A., Besir, B., Hussein, A. A., Taigen, T., Bhargava, M., Kanj, M., Baranowski, B., Jaber, W., Santangeli, P., Chung, M., Saliba, W. I., & Wazni, O. M. (2026). Outcomes of LAAO vs. DOACs in Obese Patients With Atrial Fibrillation a 5‐Year Propensity‐Matched Analysis. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70089
Vancouver
Mdaihly M, Motairek I, Younis A, Tabaja C, Demian J, Watfa A, et al. Outcomes of LAAO vs. DOACs in Obese Patients With Atrial Fibrillation a 5‐Year Propensity‐Matched Analysis. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70089
BibTeX
@article{Mdaihly2026,
author = {Mdaihly, Mohamad and Motairek, Issam and Younis, Arwa and Tabaja, Chadi and Demian, Joe and Watfa, Adele and Besir, Besir and Hussein, Ayman A and Taigen, Tyler and Bhargava, Mandeep and Kanj, Mohamed and Baranowski, Bryan and Jaber, Wael and Santangeli, Pasquale and Chung, Mina and Saliba, Walid I and Wazni, Oussama M},
title = {Outcomes of LAAO vs. DOACs in Obese Patients With Atrial Fibrillation a 5‐Year Propensity‐Matched Analysis},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
doi = {10.1111/pace.70089}
}
EUVIMED